Can Wesfarmers (ASX:WES) win the battle to take over API?

Wesfarmers and Woolworths are facing off, with the latter offering $109 million more to take over API. Here's why Wesfarmers could still triumph

| More on:
A woman in a business suit and a man in a business suit boxing in a ring.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Competition between Wesfarmers Ltd (ASX: WES) and Woolworths Group Ltd (ASX: WOW) has burst into an inferno as the pair go head to head to take over the owner of Priceline.

The latter retail giant lobbed a bid for Australian Pharmaceutical Industries Ltd (ASX: API) yesterday. Its offer surpasses Wesfarmers' longstanding takeover bid by 12.9%.

At the time of writing, the Wesfarmers share price is $57.38, 0.76% lower than its previous close.

For context, the S&P/ASX 200 Index (ASX: XJO) is currently down 0.02%.

Wesfarmers back in the ring to take over API

Wesfarmers is once again in a surprise battle to win all API's remaining shares despite its takeover offer having already been accepted by the pharmaceutical company.

API agreed to go ahead with Wesfarmers' $763 million acquisition offer earlier this month after fellow pharmaceutical company Sigma Healthcare Ltd (ASX: SIG) redacted its takeover offer.

But that could all be upset now Woolworths has outbid Wesfarmers by more than $100 million.

Both companies are looking to acquire the company – which would see them owning Priceline stores. Thus, it would see the winner expanding into the growing health, wellbeing, and beauty market.

However, Woolworths' inclusion in the battle for the pharmaceutical giant has raised the eyebrows of the Pharmacy Guild of Australia.

A spokesperson for the guild said it's looking forward to "having many conversations with the Woolworths team as well as with Prime Minister Scott Morrison and Leader of the Opposition Anthony Albanese" regarding Woolworths' potential takeover. They questioned:

Why is a company with interests in the alcohol, tobacco, gambling, and nightclub industries wanting to move into healthcare?

How does it hope to convince Australians that it is serious about their health and welfare?

How will it ensure the successful community pharmacy model, which is custodian of the PBS (Pharmaceutical Benefits Scheme), is protected and maintained?

Woolworths Group CEO Brad Banducci has stated the company would be committed to supporting API's community pharmacy partners. It will also ensure all Australians have access to a full range of PBS and other medicines. He also commented:

Health and wellness is a large, fast-growing category and API would be a fantastic addition to our food and everyday needs ecosystem.

All eyes will be on Wesfarmers and Woolworths – and their share prices – as the retail giants battle to get a foothold in the increasingly lucrative market.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Mergers & Acquisitions

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Mergers & Acquisitions

Guess which ASX All Ords stock just rocketed 23% on a $1.2 billion offer

Investors are piling into the ASX All Ords stock amid a $1.2 billion takeover bid.

Read more »

Projection of two hands being shaken on a deal.
Materials Shares

Sayona Mining shares sink 13% on Piedmont Lithium merger news and capital raise

This merger will create the largest lithium producer in North America.

Read more »

Miner looking at a tablet.
Materials Shares

Down 28% in 2024, why this ASX 200 lithium stock could now be 'deeply undervalued'

The ASX 200 lithium stock has drawn plenty of investor attention over the past month.

Read more »

Woman looking at her tablet at a warehouse.
Mergers & Acquisitions

ASX 200 stock slides on huge $13 billion buyout news

ASX 200 investors are mulling over the $13 billion merger implications on Wednesday.

Read more »

Rocket powering up and symbolising a rising share price.
Mergers & Acquisitions

Guess which ASX microcap stock just rocketed 67% on takeover news

Investors are sending the ASX microcap stock flying amid a takeover bid.

Read more »

A group of business people pump the air and cheer.
Mergers & Acquisitions

This ASX small-cap stock is exploding 75% on takeover news!

The takeover premium is large.

Read more »

Man with rocket wings which have flames coming out of them.
Mergers & Acquisitions

Guess which ASX stock just rocketed 40% on takeover news

A colossal company finds value in the small end of our ASX town.

Read more »

Data Centre Technology
Mergers & Acquisitions

ASX 200 stock nabs $400 million data centre amid AI rush

Another way to invest in the enablers of artificial intelligence is being built.

Read more »